(Q47409299)

http://europepmc.org/abstract/PMC/5888154

4 July 2018

title

Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy (English)

1 reference

http://europepmc.org/abstract/PMC/5888154

4 July 2018

1 reference

semaglutide

5 May 2024

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Lawrence A Leiter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ildiko Lingvay

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Stephen C Bain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

David Matthews

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Rafael Simó

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ida Carøe Helmark

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Nelun Wijayasinghe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Michael Larsen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

8 January 2018

1 reference

http://europepmc.org/abstract/PMC/5888154

4 July 2018

number of pages

9

1 reference

Diabetes, Obesity and Metabolism

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

889-897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment

10 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Global prevalence and major risk factors of diabetic retinopathy

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.

10 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentr

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Near-normoglycemia and late diabetic complications. The Oslo Study

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5888154

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

14 August 2018

1 reference

12 December 2020

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin.

1 reference

12 December 2020

GLP-1 agonist treatment: implications for diabetic retinopathy screening

1 reference

12 December 2020

The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy

1 reference

12 December 2020

(12) Management of diabetes in pregnancy

1 reference

12 December 2020

Identifiers

DOI

10.1111/DOM.13172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

release_zdnkesasknhxbekj7l332wgp5u

10 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zdnkesasknhxbekj7l332wgp5u

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29178519%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

PubMed publication ID

29178519

1 reference